AOP-Wiki

API

All KERs

Showing 176 to 200 of 3158 KERs

ID	Upstream Event	Downstream Event	Creation Date	Last Updated	AOPs

2127	286: Altered, Transcription of genes by the AR	1688: AGD, decreased	May 11, 2020	Feb 4, 2026	3 AOPs 305: 5α-reductase inhibition leading to short anogenital distance (AGD) in male (mammalian) offspring 306: Androgen receptor (AR) antagonism leading to short anogenital distance (AGD) in male (mammalian) offspring 307: Decreased testosterone synthesis leading to short anogenital distance (AGD) in male (mammalian) offspring
2237	1158: Increased, Hepatic thyroid hormone uptake/transport	281: T4 in serum, Decreased	Dec 9, 2020	Dec 9, 2020	3 AOPs 194: Hepatic nuclear receptor activation leading to altered amphibian metamorphosis 366: Competitive binding to thyroid hormone carrier protein transthyretin (TTR) leading to altered amphibian metamorphosis 367: Competitive binding to thyroid hormone carrier protein thyroid binding globulin (TBG) leading to altered amphibian metamorphosis
2125	413: Reduction, Testosterone synthesis in Leydig cells	1690: Decrease, circulating testosterone levels	May 11, 2020	May 1, 2024	3 AOPs 18: PPARα activation in utero leading to impaired fertility in males 51: PPARα activation leading to impaired fertility in adult male rodents 64: Glucocorticoid Receptor (GR) Mediated Adult Leydig Cell Dysfunction Leading to Decreased Male Fertility
2292	406: decreased, Fertility	360: Decrease, Population growth rate	Mar 26, 2021	Mar 26, 2021	3 AOPs 348: Inhibition of 11β-Hydroxysteroid Dehydrogenase leading to decreased population trajectory 349: Inhibition of 11β-hydroxylase leading to decresed population trajectory 592: DBDPE-induced DNA strand breaks and LDH activity inhibition leading to population growth rate decline via energy metabolism disrupt and apoptosis
2309	1172: Increased activation, Nuclear factor kappa B (NF-kB)	1496: Increased proinflammatory mediators	Mar 30, 2021	Mar 30, 2021	3 AOPs 382: Angiotensin II type 1 receptor (AT1R) agonism leading to lung fibrosis 377: Dysregulated prolonged Toll Like Receptor 9 (TLR9) activation leading to Multi Organ Failure involving Acute Respiratory Distress Syndrome (ARDS) 319: Binding to ACE2 leading to lung fibrosis
2333	1862: Decrease, Photosystem II efficiency	1475: Decrease, Photosynthesis	Apr 11, 2021	Feb 23, 2026	3 AOPs 386: Deposition of ionizing energy leading to population decline via inhibition of photosynthesis 389: Oxygen-evolving complex damage leading to population decline via inhibition of photosynthesis 567: Binding to plastoquinone B site leading to decreased population growth rate via photosystem II inhibition
1931	1635: Increase, DNA strand breaks	185: Increase, Mutations	Jun 2, 2019	Jan 9, 2023	3 AOPs 296: Oxidative DNA damage leading to chromosomal aberrations and mutations 272: Deposition of energy leading to lung cancer 644: Bulky DNA adducts leading to chromosomal aberrations and mutations
1763	1492: Tissue resident cell activation	1493: Increased pro-inflammatory mediators	Aug 2, 2018	Aug 2, 2018	3 AOPs 38: Protein Alkylation leading to Liver Fibrosis 293: Increased DNA damage leading to increased risk of breast cancer 294: Increased reactive oxygen and nitrogen species (RONS) leading to increased risk of breast cancer
1743	1523: Decrease, Cuticular chitin content	1524: Increase, Premature molting	May 24, 2018	Feb 17, 2021	3 AOPs 360: Chitin synthase 1 inhibition leading to mortality 361: Sulfonylureareceptor binding leading to mortality 606: Ecdysone receptor antagonism leading to mortality via inhibition of chitin synthase 1
1752	1366: Decrease, Oogenesis	328: Decrease, Fecundity	Jun 12, 2018	Jun 12, 2018	3 AOPs 336: DNA methyltransferase inhibition leading to population decline (1) 337: DNA methyltransferase inhibition leading to population decline (2) 338: DNA methyltransferase inhibition leading to population decline (3)
1904	1632: Increase in RONS	1194: Increase, DNA Damage	May 7, 2019	May 8, 2019	3 AOPs 293: Increased DNA damage leading to increased risk of breast cancer 294: Increased reactive oxygen and nitrogen species (RONS) leading to increased risk of breast cancer 444: Ionizing radiation leads to reduced reproduction in Eisenia fetida via reduced spermatogenesis and cocoon hatchability
1777	1493: Increased pro-inflammatory mediators	1494: Leukocyte recruitment/activation	Nov 12, 2018	Nov 12, 2018	3 AOPs 144: Endocytic lysosomal uptake leading to liver fibrosis 293: Increased DNA damage leading to increased risk of breast cancer 294: Increased reactive oxygen and nitrogen species (RONS) leading to increased risk of breast cancer
3146	177: Increase, Mitochondrial dysfunction	1262: Apoptosis	Mar 13, 2024	Mar 13, 2024	3 AOPs 205: AOP from chemical insult to cell death 207: NADPH oxidase and P38 MAPK activation leading to reproductive failure in Caenorhabditis elegans 595: Emerging OPFRS reproductive outcome pathway
3116	1392: Increase, Oxidative Stress	1445: Increase, LPO	Jan 24, 2024	Jun 23, 2026	3 AOPs 521: Essential element imbalance leads to reproductive failure via oxidative stress 331: Reactive oxygen species leading to growth inhibition via lipid peroxidation and cell death 326: Reactive oxygen species leading to growth inhibition via lipid peroxidation and decreased cell proliferation
3141	177: Increase, Mitochondrial dysfunction	1115: Increase, ROS	Mar 6, 2024	Apr 11, 2024	3 AOPs 500: Activation of MEK-ERK1/2 leads to deficits in learning and cognition via ROS and apoptosis 273: Mitochondrial complex inhibition leading to liver injury 472: DNA adduct formation leading to kidney failure
2635	1141: Decreased, Reproductive Success	360: Decrease, Population growth rate	Apr 6, 2022	Apr 6, 2022	3 AOPs 203: 5-hydroxytryptamine transporter inhibition leading to decreased reproductive success and population decline 218: Inhibition of CYP7B activity leads to decreased reproductive success via decreased locomotor activity 219: Inhibition of CYP7B activity leads to decreased reproductive success via decreased sexual behavior
3448	2298: Decrease, intratesticular testosterone	1690: Decrease, circulating testosterone levels	Dec 12, 2024	Mar 20, 2026	3 AOPs 307: Decreased testosterone synthesis leading to short anogenital distance (AGD) in male (mammalian) offspring 570: Decreased testosterone synthesis leading to hypospadias in male (mammalian) offspring 575: Decreased testosterone synthesis leading to increased nipple retention (NR) in male (rodent) offspring
3391	2251: Increased E2 availability	1065: Activation, ERα	Nov 15, 2024	Nov 21, 2024	3 AOPs 504: SULT1E1 inhibition leading to uterine adenocarcinoma via increased estrogen availability at target organ level 561: Aromatase induction leading to estrogen receptor alpha activation via increased estradiol 565: 17β-Hydroxysteroid dehydrogenase 2, inhibition leading to activation, estrogen receptor alpha
3503	1840: Inhibition, cytochrome oxidase	1825: Increase, Cell death	Mar 5, 2025	Mar 18, 2025	3 AOPs 368: Cytochrome oxidase inhibition leading to increased nasal lesions 573: Inhibition, cytochrome oxidase leads to Increased, pulmonary edema 574: Inhibition, cytochrome oxidase leads to Loss of olfactory function
3348	1614: Decrease, AR activation	1786: nipple retention, increased	Sep 26, 2024	Mar 20, 2026	3 AOPs 576: 5α-reductase inhibition leading to increased nipple retention (NR) in male (rodent) offspring 344: Androgen receptor (AR) antagonism leading to nipple retention (NR) in male (mammalian) offspring 575: Decreased testosterone synthesis leading to increased nipple retention (NR) in male (rodent) offspring
3490	1115: Increase, ROS	1634: Increase, Oxidative DNA damage	Feb 25, 2025	Feb 25, 2025	3 AOPs 299: Deposition of energy leading to population decline via DNA oxidation and follicular atresia 311: Deposition of energy leading to population decline via DNA oxidation and oocyte apoptosis 330: Excessive reactive oxygen species production leading to mortality (4)
3480	1635: Increase, DNA strand breaks	1505: Cell cycle disruption	Jan 20, 2025	Jan 20, 2025	2 AOPs 602: Excessive reactive oxygen species leading to growth inhibition via oxidative DNA damage 324: Reactive oxygen species leading to growth inhibition via oxidative DNA damage and cell cycle disruption
3496	1115: Increase, ROS	177: Increase, Mitochondrial dysfunction	Feb 25, 2025	Feb 25, 2025	2 AOPs 273: Mitochondrial complex inhibition leading to liver injury 636: Increase in reactive oxygen species (ROS) leading to human amyotrophic lateral sclerosis (ALS)
3495	1446: Decrease, Coupling of OXPHOS	1115: Increase, ROS	Feb 25, 2025	Feb 25, 2025	2 AOPs 534: Succinate dehydrogenase (SDH) inhibition leads to oxidative stress 613: Peroxisome proliferator-activated receptor alpha activation leading to early life stage mortality via increased reactive oxygen species production
3365	239: Activation, Pregnane-X receptor, NR1I2	2268: Decreased, INSIG1 protein activity	Oct 22, 2024	Feb 10, 2025	2 AOPs 545: Activation, Pregnane-X receptor, NR1I2 leads to increased plasma low-density lipoprotein (LDL) cholesterol via increased cholesterol synthesis 548: Activation, Pregnane-X receptor, NR1I2 leads to increased plasma low-density lipoprotein (LDL) cholesterol via increased PCSK9 protein expression

Key Event Relationships (KERs)

All KERs